Latest filing published 27 Dec 2022 for ABIOMED INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Chris Van Gorder (board member) discloses dealings in Abiomed Inc to SEC (Form 4). Between 8 February 2016 and 22 December 2022, the trades on record add up to 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 27 December 2022: a share grant, in Abiomed Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations